By Sarah Mendiola – Claims denials are an issue that do not merely take a financial toll on healthcare providers; they create a ripple effect that delays payment, eats up staff time and resources, and worsens the patient experience.
Read More
Joshua Liu MD explains if having access to AI Co-Pilots will help or hurt medical training.
By Devin Partida – Healthcare is constantly evolving, which means the demand for more advanced and efficient EHR systems grows stronger. Implementing these systems can be costly, but grants offer a valuable solution to alleviate financial barriers.
By Julie Schulz MD MPH – In addition to being one of the top 10 causes of death in the United States, chronic kidney disease is a significant driver of cost for commercial insurance and Medicare. However, significant costs can be avoided with earlier detection, better quality care, and aligned physician incentives.
By Ram Krishnan – As part of a broader movement across healthcare to improve patient outcomes while reducing costs, behavioral health has seen a shift toward value-based care incentivizing providers to deliver high-quality and efficient care by linking payment to patient health outcomes.
By Julie Appleby – Suspicions that U.S. consumers’ personal information could be accessed from India led regulators to abruptly bar two large private sector enrollment websites from accessing the Affordable Care Act marketplace in August.
The thought leaders in our community are good about sharing their thoughts on the issues of today. Here are the top read and shared guest posts of August that we think deserve sharing again.
Joshua Liu MD explains seven behaviors of health systems who are the most successful with digital health.
By Inga Rose & and Aaron Schlum – On May 6, FDA published a final rule that will change the way laboratory-developed tests are regulated. The rule phases out the agency’s general policy of “enforcement discretion” and mandates that, across five stages within the next four years, LDTs will be beholden to the same regulatory requirements as in vitro diagnostics.